Every 67 seconds, someone in the United States develops Alzheimer’s disease. With 10,000 Baby Boomers turning 65 every day, the number of people suffering from Alzheimer’s is on the rise — and right now, there’s no way to slow or stop the disease.
The only way we’ll end Alzheimer’s is by fully funding life-saving research for a cure.
The General Board of Church & Society is partnering with USAgainstAlzheimer’s to mobilize people of faith to take action against this devastating disease.
The only way we’ll end Alzheimer’s is by fully funding life-saving research for a cure. Congress is considering increased Alzheimer’s funding, but to make sure it passes, we need a groundswell of support.
Take action today
You can take action today to demand Congress pass critical research funding. Sign the petition: Urge Congress to support Alzheimer’s funding. Demand that Congress fund life-saving research to end Alzheimer’s.
We’ve seen the terrible toll this disease takes on our families, congregations and communities. Let’s raise our voices together on this critical issue and move toward a future without Alzheimer’s.
Editor's note: The Rev. Cynthia Abrams directs the Health & Wholeness program at the United Methodist General Board of Church & Society.
USAgainstAlzheimer’s is committed to ending Alzheimer's by 2020. USAgainstAlzheimer's presses for greater urgency from government, industry and the scientific community in the quest for an Alzheimer's cure. The organization accomplishes this through effective leadership, collaborative advocacy and strategic investments.
USAgainstAlzheimer's and the General Board of Church & Society (GBCS) of The United Methodist Church recently announced the launch of the Faith United Against Alzheimer's Coalition (FUAAC), a cooperative effort to mobilize all elements of the faith community in the fight against Alzheimer’s disease and related dementias.
As founders of the coalition, USAgainstAlzheimer’s and GBCS will work with faith-based organizations to promote dignity, compassionate care and quality of life for individuals with Alzheimer’s disease, provide support for families, and call on industry leaders, community stakeholders and policymakers to work urgently to find disease-modifying treatments and a cure.